0001209191-23-028323.txt : 20230509
0001209191-23-028323.hdr.sgml : 20230509
20230509171103
ACCESSION NUMBER: 0001209191-23-028323
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230505
FILED AS OF DATE: 20230509
DATE AS OF CHANGE: 20230509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Deborah Ann
CENTRAL INDEX KEY: 0001868741
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40671
FILM NUMBER: 23903299
MAIL ADDRESS:
STREET 1: C/O NUVALENT, INC.
STREET 2: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvalent, Inc.
CENTRAL INDEX KEY: 0001861560
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 508-446-2272
MAIL ADDRESS:
STREET 1: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-05
0
0001861560
Nuvalent, Inc.
NUVL
0001868741
Miller Deborah Ann
C/O NUVALENT, INC.
ONE BROADWAY, 14TH FLOOR
CAMBRIDGE
MA
02142
0
1
0
0
Chief Legal Officer
1
Class A Common Stock
2023-05-05
4
M
0
2800
6.89
A
2800
D
Class A Common Stock
2023-05-05
4
S
0
2800
39.64
D
0
D
Class A Common Stock
2023-05-09
4
M
0
1332
6.89
A
1332
D
Class A Common Stock
2023-05-09
4
S
0
1332
39.63
D
0
D
Stock Option (Right to Buy)
6.89
2023-05-05
4
M
0
2800
0.00
D
2031-04-29
Class A Common Stock
2800
209470
D
Stock Option (Right to Buy)
6.89
2023-05-09
4
M
0
1332
0.00
D
2031-04-29
Class A Common Stock
1332
208138
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2021.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.60 to $39.76, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.60 to $39.69, inclusive.
The shares underlying this option vest as follows: 25% of the shares vested on April 15, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
/s/ Deborah Ann Miller
2023-05-09